Elisabeth Paietta, Ph.D.¹, Xiaochun Li, Ph.D.^2*, Sue Richards^3*, Janis Racevskis, Ph.D.^1*, Gordon W. Dewald, PhD, PhD, FACMG⁴, Jacob M. Rowe, MD⁵, Martin S Tallman⁶, Hillard M Lazarus, MD^7*, Mark Litzow, M.D.^4*, Anthony H. Goldstone, FRCP, FRCPath⁸ and Peter H. Wiernik, MD^1*

¹Cancer Center, Montefiore Medical Center North Division, Bronx, NY
²Division of Biostatistics, Indiana University, Indianapolis, IN
³Ctsu, University of Oxford, Oxford, United Kingdom
⁴Mayo Clinic, Rochester, MN
⁵Hematology and Bone Marrow Transplantation, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel., Haifa, Israel
⁶Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁷Ireland Cancer Center, University Hospitals of Cleveland, Cleveland, OH
⁸Univ. College London Hosp., London, ARRAY(0xc1581ac)

Pacharapan Surapolchai, MD^1*, Suradej Hongeng, MD¹, Pat Mahachoklertwattana^1*, Samart Pakakasama, MD¹, Angkana Winaichatsak, MD^2*, Nittaya Wisanuyothin^2*, Ekawat Pasomsub^3*, Surakameth Mahasirimongkol, MD^4* and Nongnuch Sirachainan^1*

¹Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand
²Pediatrics, Maharaj Nakhonratchasima Hospital, Nakhonratchasima, Thailand
³Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand
⁴Department of Medical Science, National Institute of Health, Nondhaburi, Thailand

Jason P Yun^1*, Lars Klemm^2*, James W Behan^1*, Markus Müschen, MD, PhD³ and Steven D Mittelman, MD, PhD^1*

¹Division of Endocrinology, Childrens Hospital Los Angeles, Los Angeles, CA
²Hematology/Oncology, Childrens Hospital Los Angeles, Los Angeles, CA
³Childrens Hospital Los Angeles, Los Angeles, CA

Catrin Schult^1*, Meike Dahlhaus^1*, Sonja Boldt^2*, Änne Glass^3*, Sabine Ruck^1*, Mandy Sawitzky^1*, Sandra Lange^1*, Francesca Amoroso^1*, Mathias Freund¹, Luca Maria Neri^4* and Christian Junghanss^1*

¹Hematology/Oncology, University of Rostock, Rostock, Germany
²Systems Biology & Bioinformatics Group, University of Rostock, Rostock, Germany
³Institute for Medical Informatics and Biometry, University of Rostock, Rostock, Germany
⁴Morphology and Embryology, University of Ferrara, Ferrara, Italy

Karin von Schwarzenberg^1*, Marco Henkel^2*, Dennis Conzelmann^3*, Björn Stork^2*, Anita Bringmann^1*, Sebastian Wesselborg^2* and Peter Brossart, MD¹

¹Hem./Onc., Univ. of Bonn, Bonn, Germany
²Gastroenterology, University of Tuebingen, Tuebingen, Germany
³Hematology, Oncology, Immunology, Rheumatology and Pulmology, University of Tuebingen, Tuebingen, Germany

Hui-Jen Tsai, MD¹, Seiichiro Kobayashi, MD, PhD^2*, Kiyoko Itoh, PhD^2*, Takaomi Ishida, PhD^3*, Kazuo Umezawa, PhD^4* and Arinobu Tojo, MD, PhD²

¹Hem. Onc., Kaohsiung Med. Univ. Hosp., Kaohsiung, Taiwan
²Div of Molecular Therapy, Institute of Medical Science, Univ. of Tokyo, Tokyo, Japan
³Department of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan
⁴Faculty of Science and Technology, Keio University, Yokohama-shi, Japan

Ronald W. Stam, PhD^1*, Monique L. Den Boer, PhD¹, Pauline Schneider^1*, Jasper de Boer, PhD^2*, Jill Hagelstein, MSc^1*, Stephen E. Sallan, MD³, Hugh J.M. Brady, PhD^2*, Scott Armstrong, MD, PhD^3* and Rob Pieters, MD, PhD¹

¹Pediatric Oncology/Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, Netherlands
²Molecular Haematology and Cancer Biology Unit, UCL Institute of Child Health and Great Ormond Street Hospital, London, United Kingdom
³Dana-Farber Cancer Institute, Boston, MA

Ai Kotani^1*, Daon Ha^2*, Prakash Rao^1*, James Hsieh^3*, Diana Schotte^4*, Monique L. den Boer^4*, Scott Armstrong, MD, PhD⁵ and Harvey F. Lodish, PhD¹

¹Whitehead Institute for Biomedical Research, Cambridge, MA
²Biology, MIT, Cambridge
³Washington University, St. Louis
⁴Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
⁵Children's Hospital, Boston, MA

Aline Schmidt-Tanguy, MD^1*, Annette Romanski, PhD^1*, Mathilde Hunault-Berger, MD, PhD^2* and Oliver G. Ottmann, MD³

¹Hematology, J.W. Goethe University, Frankfurt am Main, Germany
²Service des Maladies du Sang, CHU Angers, Angers, France
³Goethe University, Frankfurt, Germany

Ali Jalili, PhD, MSc^1*, Neeta Shirvaikar, MSc^2*, Imran Mirza, FRCPC³, Sara Ilnitsky^2*, Mark Penfold, PhD^4*, Thomas J Schall, PhD^5* and Anna Janowska-Wieczorek, MD, PhD⁶

¹Div. Clinical Hematology, Medicine, University of Alberta, Edmonton, AB, Canada
²Research and Development, Canadian Blood Services, Edmonton, AB, Canada
³University of Alberta, Edmonton, AB, Canada
⁴ChemoCentryx, Inc., Mountain View, CA
⁵ChemoCentryx, Inc, Mountain View, CA
⁶Div. Clinical Hematology, Dept. of Medicine, University of Alberta, Edmonton, AB, Canada

Bridget S. Wilson, PhD^1*, Xiangbing Meng, MD^1*, Tomas Mazel, MD/PhD^1*, Cheryl L. Willman, MD¹, Susan Atlas, PhD^1*, Richard Harvey, PhD^1*, I-Ming Chen, MD^1*, Stephen P. Hunger, MD², Janet M Oliver, PhD^1* and Stuart S. Winter, MD^1*

¹University of New Mexico Cancer Center, Albuquerque, NM
²University of Colorado Denver School of Medicine and The Children's Hospital, Aurora, CO

Rahul Nahar^1*, Daniel Trageser^1*, Lars Klemm^1*, Cihangir Duy^1*, Peter van Essen^1*, Yong-mi Kim^1*, Nora Heisterkamp^1*, Giovanni Martinelli^2*, Wolf-Karsten Hofmann, MD^3*, Hans-Martin Jack^4*, Hassan Jumaa^5* and Markus Muschen¹

¹Leukemia Research Program, Childrens Hospital Los Angeles, Los Angeles, CA
²Department of Hematology/Oncology “L. and A. Seràgnoli”, University of Bologna, Italy
³MILE Study Group, on Behalf of European LeukemiaNet (ELN, WP13), Munich, Germany
⁴Molecular Immunology, University of Erlangen, Erlangen, Germany
⁵Molecular Immunology, Max-Planck-Institute for Immunology, Freiburg, Germany